Revised forecast
Fiscal year ending March 2026 · Full yearPrevious forecast published 30 April 2025The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
New releases and other products launched in the fourth quarter exceeded plan, and non-operating income and expenses significantly exceeded plan as a result of operations conducted while monitoring financial markets.
| Item | Details |
|---|---|
| Net Sales | 92,000 Millions of yen → 87,500 Millions of yen（△4.9） |
| Operating profit | 31,000 Millions of yen → 36,000 Millions of yen（+16.1%） |
| Ordinary income | 37,000 Millions of yen → 55,500 Millions of yen（+50.0%） |
| Profit attributable to owners of the parent | 27,000 Millions of yen → 41,500 Millions of yen（+53.7%） |
| Net income per share | ¥85.49 → ¥127.68 |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 30 April 2025 |
| Previous-period results | Net sales ¥83,150 million, operating profit ¥32,119 million, ordinary profit ¥49,988 million, profit attributable to owners of the parent ¥37,628 million, earnings per share ¥119.14 |
| Reason for the revision | New releases and other products launched in the fourth quarter exceeded plan, and non-operating income and expenses significantly exceeded plan as a result of operations conducted while monitoring financial markets. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Net sales and operating profit forecasts were revised because new releases and other products launched in the fourth quarter outperformed plan. Ordinary profit and profit attributable to owners of the parent were revised because non-operating income and expenses significantly exceeded plan as a result of operations conducted while monitoring financial markets.